The page is the record's research on the issuer — no analyst, no rating, no view. # Vicore Pharma Holding AB (NASDAQ: VCRE) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Vicore Pharma Holding AB, listed on NASDAQ under ticker VCRE, with ISIN US92581R1041. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-V7. The security type is non-operating entity type (other), sector 2834 Pharmaceutical Preparations, jurisdiction Sweden, and segment not on the record. The issuer is listed and not halted. ## The disclosure read The record holds 13 filings in the window 2025-11-08 to 2026-11-08, across 11 filing days, of which 7 are regulatory filings and 6 are results. The median gap between filing days is 15.5 days. The latest filing is dated 2026-11-05, a results filing, 3 days before the record date of 2026-11-08. On NASDAQ the median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days across 4359 issuers. In sector 2834 Pharmaceutical Preparations the median cadence gap is 6.0 days, the median filings count is 63.0, and the median latency is 4.0 days across 526 issuers. ## Auditor The auditor of record is not on the record, as the latest annual report cover carries no dei:AuditorName tag, and the auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds one lifecycle line, a listing dated 2026-06-30. It holds no delisting, name change, or domicile change, and the segment move is not on the record. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The halt flag reads listed, not halted. ## Orderability The orderability outcome is not determinable, as the chapter's orderability section carries no client categories and the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage The record finds 11 research houses named on the issuer's investor-relations page: ABG Sundal Collier, Cantor, Danske Bank, DNB Carnegie, Guggenheim, Jefferies, Pareto Securities, Stifel, Van Lanschot Kempen, Arctic Securities, and Chardan. ## Open research The record holds one openly published research note, by Goetzpartners Healthcare Research, dated 2018-03-22. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0002124403.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/VCRE (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://vicorepharma.com/investerare/aktieinformation-2/analytiker/ (coverage) - http://vicorepharma.com/wp-content/uploads/2019/06/goetz-partners-vph-180322.pdf (open research) - https://mcp.us-cm-kg.ai/record/NASDAQ/VCRE (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/VCRE · public-record only · the same page signed and receipted: get_research at https://mcp.getissuer.ai/mcp